Fractional Exhaled Nitric Oxide (FeNO) Result Prediction Factors in Children With Allergic Diseases
NCT ID: NCT00815984
Last Updated: 2010-02-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
800 participants
OBSERVATIONAL
2009-01-31
2010-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
PF and FeNO and Clinical Characteristics in Children Being Diagnosed Due to Suspicion of Allergic Diseases
NCT01805635
Nasal Budesonide Efficacy on Nasal FeNO in Children With Allergic Rhinitis
NCT02409563
Comparison of the Effect of Montelukast and Cetirizine on Allergic Inflammation in Children With Allergic Rhinitis
NCT00488176
FeNO as a Marker of Allergic Reactions to OFC and Response of OMA Treatment in Multiple FA
NCT06437171
Evaluation of Different Disease Control Indices in Children With Asthma and Rhinitis
NCT00952835
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Schoolchildren with asthma.
Schoolchildren with asthma.
measurements of lung function tests
Measurement of the concentration of FeNO , measurement of spirometry, plethysmography, exercise challenge test (ECT -spirometric), bronchial obstruction reversibility pharmacological test
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
measurements of lung function tests
Measurement of the concentration of FeNO , measurement of spirometry, plethysmography, exercise challenge test (ECT -spirometric), bronchial obstruction reversibility pharmacological test
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Asthma exacerbation
* Pregnancy
5 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Lodz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Department of Pediatrics and Allergy, N. Copernicus Hospital, Lodz, Poland
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Iwona Stelmach, MD PhD Prof
Role: STUDY_CHAIR
Department of Pediatrics and Allergy, N. Copernicus Hospital, Lodz, Poland
Tomasz Grzelewski, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Pediatrics and Allergy, N. Copernicus Hospital, Lodz, Poland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Pediatrics and Allergy, N. Copernicus Hospital
Lodz, , Poland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Grzelewski T, Majak P, Jerzynska J, Stelmach W, Stelmach R, Janas A, Grzelewska A, Witkowski K, Makandjou-Ola E, Stelmach I. The interpretation of exhaled nitric oxide values in children with asthma depends on the degree of bronchoconstriction and the levels of asthma severity. Respir Care. 2014 Sep;59(9):1404-11. doi: 10.4187/respcare.02889. Epub 2013 Dec 31.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RNN/135/08/KE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.